Report Overview

Global Biopharmaceutical Logistics Market: Overview

Logistics is a key segment in the biopharmaceutical supply chain. In an organization, logistics management with the procurement, planning, and implementation of process activities in the forward and turn around the transportation of goods from one spot on to the next. Biopharmaceutical Logistics is the logistics of biopharmaceutical, surgical and medical supplies, and other products needed to support health specialists, nurses, and dental care providers.

The rising number of biosimilar endorsements around the globe, developing trend of outsourcing logistics, and development in pharmaceutical distribution network owing to its sales numbers are some of the factors that are inciting the growth of the biopharmaceutical logistics market. Nations around the world are tightening their guidelines and regulations to ensure secure and dependable transportation of pharmaceutical shipments. This has constrained key players to investigate novel technologies to pace up with international standards and guidelines. Such as the European Union (EU) is focusing on strengthening good distribution practices (GDP) guidelines. Given the scenario, companies in the region revamping their technological and regulatory expertise. In line with these developments, investments in biopharmaceutical have extensively expanded, in this way giving the biopharmaceutical logistic market critical the driving force in the forecasted period.

Global Biopharmaceutical Logistics Market forecast and Trends

Global the market size of the Biopharmaceutical Logistics Market is anticipated to reach US$ 122.2 Bn with a decent CAGR of 6.7% within the forecast period from 2015 to 2025. In 2015, the global biopharmaceutical logistics market was valued at around US$72.3 Bn. This presents an incremental value of Biopharmaceutical The logistic market provide a decent opportunity for growth amidst the players in the market, both regional and global.

Growing the upsurge in the production of biologics, hormone medications, vaccine and complex proteins that require cold chain shipment has additionally propelled the growth of the biopharmaceutical logistic market. As follows, conveyance and transportation of pharmaceutical products that require a specific temperature witnessed a considerable growth of the biopharmaceutical logistics market.

Growth drivers

Strong biopharmaceutical sales coupled with the rapidly growing biopharmaceutical industry

Biopharmaceuticals the industry currently generates global revenues of $162 billion, making up about 20 percent of the pharma market. The efficacy and safety of biopharmaceutical products, combined with their ability to address previously untreatable conditions allows pharma companies to command high sales for innovative drugs in the global market. Strong demand for global export-import of this drug is the main driven factor for Biopharmaceutical Logistic industry in the entire globe in the current and forecasted duration.

High investments in the biopharmaceutical innovations and advancements

In 2011 alone, pharmaceutical companies invested over USD $134 billion on research and development (R&D) of new vaccines and medicines to improve patients’ daily lives. Despite the growing scientific and regulatory challenges of the past decade, over 342 new medicines have been introduced since 2002. A large the proportion of the global health gains seen over the past century can be attributed to the innovative biopharmaceutical product logistic market globally.

Restraints

The high cost of transportation

Alliance of factors and economic developments lies behind the rising transportation costs. The demand-supply imbalance of freight transport services and oil prices, is a repercussion of trade growth that has outpaced the availability of transport services to such an extent that it has led to serious issues of congestion and capacity constraint in the global biopharmaceutical logistics market. Companies have made significant improvements to manufacturing, service and maintenance operations through innovative techniques: eliminating waste, variability and inflexibility in their systems and reducing costs by up to 50% in the process. The operations of companies can save approximately 20-50% in warehousing and up to 40% in transportation.

Global Biopharmaceutical Logistics Market: Logistic Type analysis

Based on type, the global biopharmaceutical logistics market can be bifurcated into cold chain logistics and non-cold chain logistics. With an estimated share of nearly 80%, the non-cold chain logistics segment emerged dominant in the market in 2015. On account of the increasing use of biologics, the demand for Cold chain logistics is expected to witness significant growth over the forecast period. This is attributed to the rising demand for biologics over the past decade that requires temperature-controlled distribution. Moreover, the growing demand for cellular therapies, vaccines, and blood products are further driving the growth of the biopharmaceutical logistics market.

Global Biopharmaceutical Logistics Market: Mode of Transportation

The objective of the Study:

• To analyze and forecast the global Biopharmaceutical Logistics market size of the market, in terms of value.
• To examine the careful market segmentation and forecast the market size, in terms of value, based on the region by segmenting the Global Biopharmaceutical Logistics market into five regions, namely, North America, Europe, Asia Pacific, Middle East, South America and its leading countries.
• To outline, categorized and forecast the global Biopharmaceutical Logistics market based on the product type, application, and end-user.
• To examine competitive developments like technological advancement, services, and regulative the framework within the global Biopharmaceutical Logistics Market.
• To highlight the impact analysis of the factors, affecting the market dynamics such as drivers, restraints, opportunities, and challenges.
• To strategically profile the key players and comprehensively analyze their market shares along with detailing the competitive landscape for market leaders.

Scope of the Report

By Logistic Type

·         Cold Chain Logistics

·         Non-cold Chain Logistics

By Product Type

·         Generic Drugs

·         Branded Drugs

By Mode of Transportation

·         Air Shipping

·         Sea Shipping

·         Road Shipping

·         Rail Shipping

By Retail Format

·         Specialty stores

·         Hyper markets

·         Departmental Stores

·         Other Retailers

By Region:

•         North America

•         Europe

•         Asia Pacific (APAC)

•         South America

•         Middle East & Africa

Competitive Landscape

·         Deutsche Post DHL

·         Kuehne + Nagel

·         DB Schenker FedEx

·         AmerisourceBergen

·         UPS (Marken)

·         XPO Logistics

·         Panalpina

·         VersaCold

·         Agility

·         DSV

·         Nippon Express

·         GEODIS

·         Sinotrans

·         Kerry Logistics

·         SF Express

·         Other Prominent Players

Business Questions answer by the report

•         How will the market drivers, restraints, and opportunities affect the market dynamics?

•         What will be the market size in terms of value and volume and market statistics with a detailed classification?

•         Which segment dominates the market or region and one will be the fastest-growing and why?

•         A comprehensive survey of the competitive landscape and the market participant players

•         Analysis of strategy adopted by the key player and their impact on other players.

Customization Scope for the Client

Client satisfaction is our first and last priority and that’s why BlueWeave Consulting offers customization according to Company’s specific needs. The following customization options are available for the report:

Additional Company Information

·         With five additional company detail analysis

·         Additional country analysis

·         Detailed segment analysis

1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents

2.5. Market Size Estimation

2.6. Assumption for the Study

2.7. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Biopharmaceutical Logistics Industry Insights

4.1. Industry Value Chain Analysis

4.1.1.   Vendor Matrix

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Technological Landscape

4.4. Regulatory Framework

4.5. Company market share analysis,2018

4.6. Porter’s Five forces analysis

4.6.1.   Bargaining Power of Suppliers

4.6.2.   Bargaining Power of Buyers

4.6.3.   Threat of New Entrants

4.6.4.   Threat of Substitutes

4.6.5.   Intensity of Rivalry

4.7. PESTEL Analysis

4.8. Strategic Outlook

5.    Global Biopharmaceutical Logistics Market Overview

5.1. Market Size & Forecast 2015-2025

5.1.1.   By Value (USD)

5.2. Market Share & Forecast

5.2.1.   By Logistics Type

5.2.1.1.       Cold Chain Logistics

5.2.1.2.       Non-cold Chain Logistics

5.2.2.   By Product Type

5.2.2.1.       Generic Drugs

5.2.2.2.       Branded Drugs

5.2.3.   By Mode of Transportation

5.2.3.1.       Air Shipping

5.2.3.2.       Sea Shipping

5.2.3.3.       Road Shipping

5.2.3.4.       Rail Shipping

5.2.4.   By Retail Format

5.2.4.1.       Specialty Stores

5.2.4.2.       Hyper Markets

5.2.4.3.       Departmental Stores

5.2.4.4.       Other Retailers

5.2.5.   By Region

5.2.5.1.       North America

5.2.5.2.       Europe

5.2.5.3.       Asia Pacific

5.2.5.4.       Latin America

5.2.5.5.       Middle East & Africa

6.    North America Biopharmaceutical Logistics Market

6.1. Key Regional Trends

6.2. Market estimates & forecast

6.2.1.   By Logistic Type

6.2.2.   By Product Type

6.2.3.   By Mode of Transportation

6.2.4.   By Retail Format

6.2.5.   By Country

6.2.5.1.       U.S

6.2.5.2.       Canada

7.    Europe Biopharmaceutical Logistics Market

7.1. Key Regional Trends

7.2. Market estimates & forecast

7.2.1.   By Logistic Type

7.2.2.   By Product Type

7.2.3.   By Mode of Transportation

7.2.4.   By Retail Format

7.2.5.   By Country

7.2.5.1.       Germany

7.2.5.2.       U.K

7.2.5.3.       France

7.2.5.4.       Italy

7.2.5.5.       Rest of Europe

8.    Asia Pacific Biopharmaceutical Logistics Market

8.1. Key Regional Trends

8.2. Market estimates & forecast

8.2.1.   By Logistic Type

8.2.2.   By Product Type

8.2.3.   By Mode of Transportation

8.2.4.   By Retail Format

8.2.5.   By Country

8.2.5.1.       China

8.2.5.2.       India

8.2.5.3.       Japan

8.2.5.4.       Rest of APAC

9.    Latin America Biopharmaceutical Logistics Market

9.1. Key Regional Trends

9.2. Market estimates & forecast

9.2.1.   By Logistic Type

9.2.2.   By Product Type

9.2.3.   By Mode of Transportation

9.2.4.   By Retail Format

9.2.5.   By Country

9.2.5.1.       Brazil

9.2.5.2.       Argentina

9.2.5.3.       Rest of Latin America

10. Middle East & Africa Biopharmaceutical Logistics Market

10.1.             Key Regional Trends

10.2.             Market estimates & forecast

10.2.1. By Logistic Type

10.2.2. By Product Type

10.2.3. By Mode of Transportation

10.2.4. By Retail Format

10.2.5. By Country

10.2.5.1.    Saudi Arabia

10.2.5.2.    UAE

10.2.5.3.    South Africa

10.2.5.4.    Rest of MEA

11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)*

11.1.             Deutsche Post DHL

11.2.             Kuehne + Nagel

11.3.             DB Schenker FedEx

11.4.             AmerisourceBergen

11.5.             UPS (Marken)

11.6.             XPO Logistics

11.7.             Panalpina

11.8.             VersaCold

11.9.             Agility

11.10.          DSV

11.11.          Other Prominent Players

12. Strategic Recommendation

*Financial Details Not Be Captured in Case of Unlisted Companies

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable